Bcl-2 Antikörper (Thr56)
Kurzübersicht für Bcl-2 Antikörper (Thr56) (ABIN2134587)
Target
Alle Bcl-2 (BCL2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Thr56
-
Immunogen
- BCL2 antibody was raised in Rabbit using This antiserum was produced against synthesized non-phosphopeptide derived from human BCL2 around the phosphorylation site of Thr56 as the immunogen
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB: 1:500-1:1000, IHC: 1:50-1:100, ELISA: 1:10000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- Lot specific
-
Buffer
- PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Store at -20 °C for 1 year
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C for 1 year
-
-
- Bcl-2 (BCL2) (B-Cell CLL/lymphoma 2 (BCL2))
-
Andere Bezeichnung
- BCL2
-
Pathways
- MAPK Signalweg, PI3K-Akt Signalweg, Apoptose, Caspase Kaskade in der Apoptose, Regulation of Muscle Cell Differentiation, Cell-Cell Junction Organization, Skeletal Muscle Fiber Development, Autophagie, Smooth Muscle Cell Migration, Negative Regulation of intrinsic apoptotic Signaling
Target
-